SIDONIE SALMON: Open Payments
NPI 1679115067 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,059 in 85 payments from 17 companies in 2025. Trend: 2023 $1,061 · 2024 $1,458 · 2025 $2,059
Food & beverage: $1,960Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $328 |
| ABBVIE INC. | 17 | $303 |
| Lilly USA, LLC | 10 | $246 |
| Astellas Pharma US Inc | 8 | $192 |
| Phathom Pharmaceuticals, Inc. | 5 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $180 |
| Amgen Inc. | 7 | $167 |
| Novo Nordisk Inc | 7 | $117 |
| Exact Sciences Corporation | 4 | $73 |
| Indivior Inc. | 3 | $62 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, VOQUEZNA, CAPLYTA, EVENITY, Veozah, JARDIANCE.
Industry payments across DE — which companies pay providers there.
